Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$295.87NASDAQ Previous Close - Last Trade as of 4:00PM ET 9/20/19

Today's Change+9.72(3.40%)
Bid (Size)$285.02 (8)
Ask (Size)$295.85 (1)
Day Low / High$286.68 - 297.64
Volume1.7 M

View Biotechnology IndustryPeer Comparison as of 09/20/2019


Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $295.87
Change: +9.72 (3.40%)
Volume: 1.7 M
4:00PM ET 9/20/2019

Agilent Technologies Inc ( NYSE )

Price: $77.97
Change: -0.10 (0.13%)
Volume: 4.6 M
6:30PM ET 9/20/2019

Alexion Pharmaceuticals Inc ( NASDAQ )

Price: $106.32
Change: +0.65 (0.62%)
Volume: 2.6 M
4:00PM ET 9/20/2019

Biogen Inc ( NASDAQ )

Price: $238.79
Change: +3.17 (1.35%)
Volume: 3.8 M
3:59PM ET 9/20/2019

Illumina Inc ( NASDAQ )

Price: $309.57
Change: +4.37 (1.43%)
Volume: 1.8 M
3:59PM ET 9/20/2019

Read more news Recent News

Stocks Slide After Chinese Trade Delegation Cancels Visits to US Agricultural States
4:46PM ET 9/20/2019 MT Newswires

Stocks ended lower Friday after an agriculture delegation from China cancelled a visit to Montana as trade talks were being held in Washington. Nicole...

Sector Update: Health Care Stocks Resist Afternoon Selloff
3:57PM ET 9/20/2019 MT Newswires

Top Health Care Stocks JNJ +1.20% PFE +0.23% ABT +0.52% MRK +2.10% AMGN +0.77% Health care stocks still were rising Friday afternoon, with the NYSE Health...

Sector Update: Another Strong Advance for Health Care Stocks Friday
1:28PM ET 9/20/2019 MT Newswires

Top Health Care Stocks JNJ +0.9% PFE +0.26% ABT -0.37% MRK +1.4% AMGN +0.7% Health care stocks were rising, with the NYSE Health Care Index climbing...

Regeneron Rises 3% on CHMP Backing for Dupixent as Add-On Therapy With Intranasal Corticosteroids
1:13PM ET 9/20/2019 MT Newswires

Regeneron Pharmaceuticals (REGN) shares were up 3% in midday trading Friday after the European Medicines Agency's Committee for Medicinal Products for...

View all Commentary and Analysis

Top Research Reports for Target, Illumina & T-Mobile US
1:14PM ET 9/20/2019 Zacks

Top Research Reports for Target, Illumina & T-Mobile US

Regenxbio And RGX-501 In Homozygous Familial Hypercholesterolemia
8:44PM ET 9/19/2019 Seeking Alpha

Healthcare And Biotechnology Dashboard - Update
2:10AM ET 9/18/2019 Seeking Alpha

Why Regeneron Is Still A Deep Value Play
5:15AM ET 9/17/2019 Seeking Alpha

Company Profile

Business DescriptionRegeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. View company web site for more details
Address777 Old Saw Mill River Road
Tarrytown, New York 10591-6707
Number of Employees7,400
Recent SEC Filing09/12/20194
Co-President, Chief Executive Officer & DirectorLeonard S. Schleifer
Co-President, Director & Chief Scientific OfficerGeorge Damis Yancopoulos
Chief Financial Officer & Executive VP-FinanceRobert E. Landry
Chief Compliance Officer & Senior Vice PresidentBeth F. Levine

Company Highlights

Price Open$288.75
Previous Close$286.15
52 Week Range$271.57 - 442.00
Market Capitalization$31.9 B
Shares Outstanding108.0 M
SectorHealth Technology
Next Earnings Announcement11/05/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings16.45
Earnings per Share$18.80
Beta vs. S&P 500N/A
Revenue$6.7 B
Net Profit Margin28.59%
Return on Equity23.10%

Analyst Ratings as of 08/30/2019

Consensus RecommendationConsensus Icon
Powered by Factset